Disruption of a single copy of the p38α MAP kinase gene leads to cardioprotection against ischemia-reperfusion

被引:60
作者
Otsu, K
Yamashita, N
Nishida, K
Hirotani, S
Yamaguchi, O
Watanabe, T
Hikoso, S
Higuchi, Y
Matsumura, Y
Maruyama, M
Sudo, T
Osada, H
Hori, M
机构
[1] Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Med Informat Sci, Suita, Osaka 5650871, Japan
[3] RIKEN, Antibiot Lab & Bioarchitect Grp, Wako, Saitama 3510198, Japan
关键词
ischemia-reperfusion; p38 mitogen-activated protein kinase; heart; cardioprotection; necrosis;
D O I
10.1016/S0006-291X(03)00096-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p38 mitogen-activated protein kinase (p38) is activated in the heart during ischemia-reperfusion. However, it is not clear whether the activation of p38 is the protective response or the kinase mediates the cellular damage by ischemia-reperfusion. We examined the role of p38alpha in ischemia-reperfusion injury by studying p38alpha(+/-) mice. The p38alpha protein level in the p38alpha(+/-) heart was 50+/-8.7% compared with that in the p38alpha(+/+) heart. Upon reperfusion following ischemia for 25 min, p38alpha activity was transiently increased. The maximum level of p38 activity in p38alpha(+/-) was 60+/-10.5% compared with that in p38alpha(+/+). In the p38alpha(+/+) heart, 25 min ischemia and 2 h reperfusion resulted in necrotic injury (37.1+/-2.7% of the area at risk), whereas infarct size was drastically reduced to 7.2+/-0.7% in the P38alpha(+/-) heart. These suggested that p38alpha plays a pivotal role in the signal transduction pathway mediating myocardial cell death caused by ischemia-reperfusion. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:56 / 60
页数:5
相关论文
共 27 条
  • [1] Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development
    Adams, RH
    Porras, A
    Alonso, G
    Jones, M
    Vintersten, K
    Panelli, S
    Valladares, A
    Perez, L
    Klein, R
    Nebreda, AR
    [J]. MOLECULAR CELL, 2000, 6 (01) : 109 - 116
  • [2] Deficiency of the stress kinase p38α results in embryonic lethality:: Characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells
    Allen, M
    Svensson, L
    Roach, M
    Hambor, J
    McNeish, J
    Gabel, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) : 859 - 869
  • [3] MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure
    Arber, S
    Hunter, JJ
    Ross, J
    Hongo, M
    Sansig, G
    Borg, J
    Perriard, JC
    Chien, KR
    Caroni, P
    [J]. CELL, 1997, 88 (03) : 393 - 403
  • [4] Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion
    Bogoyevitch, MA
    GillespieBrown, J
    Ketterman, AJ
    Fuller, SJ
    BenLevy, R
    Ashworth, A
    Marshall, CJ
    Sugden, PH
    [J]. CIRCULATION RESEARCH, 1996, 79 (02) : 162 - 173
  • [5] Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059 -: SB 203580 also inhibits thromboxane synthase
    Börsch-Haubold, AG
    Pasquet, S
    Watson, SP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) : 28766 - 28772
  • [6] The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs)
    Clerk, A
    Sugden, PH
    [J]. FEBS LETTERS, 1998, 426 (01) : 93 - 96
  • [7] Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
    Ma, XL
    Kumar, S
    Gao, F
    Louden, CS
    Lopez, BL
    Christopher, TA
    Wang, CL
    Lee, JC
    Feuerstein, GZ
    Yue, TL
    [J]. CIRCULATION, 1999, 99 (13) : 1685 - 1691
  • [8] An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia
    Mackay, K
    Mochly-Rosen, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) : 6272 - 6279
  • [9] Antiischemic effects of SB203580 are mediated through the inhibition of p38α mitogen-activated protein kinase -: Evidence from ectopic expression of an inhibition-resistant kinase
    Martin, JL
    Avkiran, M
    Quinlan, RA
    Cohen, P
    Marber, MS
    [J]. CIRCULATION RESEARCH, 2001, 89 (09) : 750 - 752
  • [10] Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2
    Maulik, N
    Yoshida, T
    Zu, YL
    Sato, M
    Banerjee, A
    Das, DK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (05): : H1857 - H1864